IP Library Granted Patent US 10,351,867
Granted Patent B2
US 10,351,867 · App. 14/772,066 · Granted Jul 16, 2019

Methods and compositions for targeting RNA polymerases and non-coding RNA biogenesis to specific loci

Inventors: Steve E. Jacobsen (Agoura Hills, CA); Javier Gallego-Bartolomé (Beverly Hills, CA)
Assignee: The Regents of the University of California
C12N15/8218C07K14/415C12N15/8216
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,351,867
App. No.
14/772,066
Granted
Jul 16, 2019
Kind
B2
Abstract

The present disclosure relates to recombinant proteins that induce epigenetic gene silencing and to methods of using such proteins for reducing the expression of genes in plants.

Claims (19)

1. A method for producing a plant with reduced expression of one or more target nucleic acids, comprising:

(a) providing a plant comprising a recombinant nucleic acid, wherein the recombinant nucleic acid encodes a recombinant polypeptide comprising a first amino acid sequence comprising a DNA-binding domain and a second amino acid sequence comprising a plant DMS3 polypeptide, wherein the second amino acid sequence comprises an amino acid sequence that is at least 95% identical to SEQ ID NO: 41; and

(b) growing the plant under conditions whereby the recombinant polypeptide encoded by the recombinant nucleic acid is expressed and binds to the one or more target nucleic acids, thereby reducing expression of the one or more target nucleic acids to produce the plant with reduced expression of the one or more target nucleic acids.

2. The method of claim 1 , wherein the DNA-binding domain comprises a zinc finger domain.

3. The method of claim 1 , wherein the DNA-binding domain is selected from the group consisting of a TAL effector targeting domain, a helix-turn-helix family DNA-binding domain, a basic domain, a ribbon-helix-helix domain, a TBP domain, a barrel dimer domain, a real homology domain, a BAH domain, a SANT domain, a Chromodomain, a Tudor domain, a Bromodomain, a PHD domain, a WD40 domain, and a MBD domain.

4. The method of claim 1 , wherein the DNA-binding domain comprises a TAL effector targeting domain.

5. The method of claim 1 , wherein the second amino acid sequence comprises an amino acid sequence that is 100% identical to SEQ ID NO: 41.

6. The method of claim 1 , wherein the one or more target nucleic acids are endogenous nucleic acids.

7. The method of claim 1 , wherein the one or more target nucleic acids are heterologous nucleic acids.

8. The method of claim 1 , wherein expression of the one or more target nucleic acids is silenced.

9. A plant cell comprising a recombinant nucleic acid encoding a recombinant polypeptide comprising a first amino acid sequence comprising a DNA-binding domain and a second amino acid sequence comprising a plant DMS3 polypeptide, wherein the second amino acid sequence comprises an amino acid sequence that is at least 95% identical to SEQ ID NO: 41.

10. The plant cell of claim 9 , wherein the second amino acid sequence comprises an amino acid sequence that is 100% identical to SEQ ID NO: 41.

11. The plant cell of claim 9 , wherein the DNA-binding domain comprises a zinc finger domain.

12. The plant cell of claim 9 , wherein the DNA-binding domain is selected from the group consisting of a TAL effector targeting domain, a helix-turn-helix family DNA-binding domain, a basic domain, a ribbon-helix-helix domain, a TBP domain, a barrel dimer domain, a real homology domain, a BAH domain, a SANT domain, a Chromodomain, a Tudor domain, a Bromodomain, a PHD domain, a WD40 domain, and a MBD domain.

13. The plant cell of claim 9 , wherein the DNA-binding domain comprises a TAL effector targeting domain.

14. The method of claim 1 , further comprising:

(c) crossing the plant with reduced expression of the one or more target nucleic acids to a second plant to produce one or more F1 plants with reduced expression of the one or more target nucleic acids.

15. The method of claim 14 , further comprising:

(d) selecting from the one or more F1 plants with reduced expression of the one or more target nucleic acids an F1 plant that (i) lacks the recombinant nucleic acid, and (ii) has reduced expression of the one or more target nucleic acids.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 30, 2017
From: GALLEGO-BARTOLOMÉ, JAVIER
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 042625/0125 →
CONFIRMATORY LICENSE Recorded Dec 16, 2015
From: UNIVERSITY OF CALIFORNIA LOS ANGELES
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 037302/0516 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNMENT DOCUMENT AND EXECUTION DATE PREVIOUSLY RECORDED ON REEL 036472 FRAME 0003. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Oct 28, 2015
From: JACOBSEN, STEVEN E.
To: HOWARD HUGHES MEDICAL INSTITUTE
Reel/Frame 036989/0767 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 1, 2015
From: JACOBSEN, STEVEN E.
To: HOWARD HUGHES MEDICAL INSTITUTE
Reel/Frame 036472/0003 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 1, 2015
From: LAW, JULIE; JOHNSON, LIANNA
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 036472/0011 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 1, 2015
From: HOWARD HUGHES MEDICAL INSTITUTE
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 036472/0017 →
Continuity (3)
Provisional Application 61929414 · Jan 20, 2014
Provisional Application 61771743 · Mar 1, 2013
Related Publication 20160017348A1 · Jan 21, 2016